These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8721283)

  • 1. Evaluation of a fluorescence polarographic immunoassay with increased sensitivity for measurement of low concentrations of tobramycin in serum.
    Touw DJ; de Graaf AI; de Goede P
    Ther Drug Monit; 1996 Apr; 18(2):189-93. PubMed ID: 8721283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.
    White LO; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay.
    Keevil BG; Lockhart SJ; Cooper DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 794(2):329-35. PubMed ID: 12954384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term accuracy of fluorescence polarization immunoassays for gentamicin, tobramycin, netilmicin and vancomycin.
    Joos B; Lüthy R; Blaser J
    J Antimicrob Chemother; 1989 Nov; 24(5):797-803. PubMed ID: 2599999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the homogeneous substrate-labeled fluorescent immunoassay for tobramycin in serum.
    Belpaire FM; Hallynck T; Pyck J
    Methods Find Exp Clin Pharmacol; 1982; 4(4):249-53. PubMed ID: 6750285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a fluorescence polarization immunoassay for lorazepam quantification.
    Agbuya PG; Li L; Miles MV; Zaritsky AL; Morris AD
    Ther Drug Monit; 1996 Apr; 18(2):194-9. PubMed ID: 8721284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzyme immunoassay for serum tobramycin.
    Kominami G; Nakamura M; Mori S; Kono M
    Clin Chim Acta; 1981 Dec; 117(2):189-97. PubMed ID: 7030524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operator error: a critical determinant of false amikacin and tobramycin concentrations using fluorescence polarization immunoassay kits and TDX analyzer.
    Banerjee SK; Wells A; Dasgupta A
    Ther Drug Monit; 1999 Oct; 21(5):540-3. PubMed ID: 10519452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of three methods for measuring gentamicin and tobramycin in serum.
    Ngui-Yen JH; Hofmann T; Wigmore M; Smith JA
    Antimicrob Agents Chemother; 1981 Dec; 20(6):821-5. PubMed ID: 7034643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-determination of tobramycin in serum by high-performance liquid chromatography with ultraviolet detection.
    Barends DM; Zwaan CL; Hulshoff A
    J Chromatogr; 1981 Oct; 225(2):417-26. PubMed ID: 7298775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of enzyme-multiplied immunoassay technique with fluorescence polarization immunoassay for determination of gentamicin and tobramycin levels in serum.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Clin Microbiol; 1984 Nov; 20(5):866-8. PubMed ID: 6392321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of tobramycin by solid-phase immunofluorescence.
    Gerson B; Dean L; Bell F
    Ther Drug Monit; 1981; 3(2):167-9. PubMed ID: 7022771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-antibody fluorescence immunoassay of tobramycin.
    Karnes HT; Gudat JC; O'Donnell CM; Winefordner JD
    Clin Chem; 1981 Feb; 27(2):249-52. PubMed ID: 7006857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical assay, involving liquid chromatography, for aminoglycoside antibiotics in serum.
    Bäck SE; Nilsson-Ehle I; Nilsson-Ehle P
    Clin Chem; 1979 Jul; 25(7):1222-5. PubMed ID: 455641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of four gentamicin and tobramycin assay procedures for clinical laboratories.
    Witebsky FG; Sliva CA; Selepak ST; Ruddel ME; MacLowry JD; Johnson EE; Elin RJ
    J Clin Microbiol; 1983 Oct; 18(4):890-4. PubMed ID: 6630468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of antimicrobial agents in cerebrospinal fluid using the Abbott TDx analyzer.
    Jandreski MA; Garbincius J
    J Clin Lab Anal; 1993; 7(5):263-8. PubMed ID: 8410486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
    Zaera S; Hermida J; Tutor JC
    Ther Drug Monit; 2002 Dec; 24(6):696-700. PubMed ID: 12451284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogeneous enzyme immunoassay for tobramycin evaluated and compared with a radioimmunoassay.
    Woo J; Longley MA; Cannon DC
    Clin Chem; 1982 Jun; 28(6):1370-4. PubMed ID: 7042123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of teicoplanin in serum: comparison of high-performance liquid chromatography and fluorescence polarization immunoassay.
    McCann SJ; White LO; Keevil B
    J Antimicrob Chemother; 2002 Jul; 50(1):107-10. PubMed ID: 12096014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.